1. The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus. Issue 7 (20th February 2015) Authors: Alexander, Tobias; Sarfert, Ramona; Klotsche, Jens; Kühl, Anja A; Rubbert-Roth, Andrea; Lorenz, Hannes-Martin; Rech, Jürgen; Hoyer, Bimba F; Cheng, Qingyu; Waka, Aderajew; Taddeo, Adriano; Wiesener, Michael; Schett, Georg; Burmester, Gerd-Rüdiger; Radbruch, Andreas; Hiepe, Falk; Voll, Reinhard E Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 7(2015) Page Start: 1474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗